Here are four key notes:
1. Two analysts gave the shares a “buy” rating.
2. Eleven analysts rated the shares “neutral.”
3. No analysts rated the sells a “sell” or “strong sell.”
4. Last month, Berenberg Bank reiterated Smith & Nephew’s “buy” rating.
More articles on devices:
Dr. Kenneth Zaslav performs Virginia’s first meniscus replacement using NUsurface Implant — 4 highlights
Midwest Orthopaedic Institute offers new technology for back pain treatment: 4 insights
Orthofix upgraded to ‘strong buy’ rating — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.